Skip to main content
. 2017 May 5;17:843–853. doi: 10.1016/S1473-3099(17)30242-6

Figure 2.

Figure 2

Serum antibody unadjusted geometric mean titres

Measurements at baseline (day of screening), and 4 weeks (day 84) and 24 weeks (day 224) after the third injection of P2-VP8-P[8] vaccine or placebo. (A) Anti-P2-VP8-P[8] IgA; (B) anti-P2-VP8-P[8] IgG; (C) neutralising antibodies to Wa rotavirus strain; and (D) neutralising antibodies to 89-12 rotavirus strain. At 24 weeks, all infants had received three doses of Rotarix except one infant in the 10 μg group, three infants in the 30 μg group, and one infant in the 60 μg group, who received only one or two doses. Error bars show 95% CI.